Skip to main content
VIKAS LIFECARE LIMITED logo

VIKAS LIFECARE LIMITED — Investor Relations & Filings

Ticker · VIKASLIFE ISIN · INE161L01027 LEI · 9845008856U9D9DABE98 BSE.NS Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2025-08-16 Regulatory Filings
Country IN India
Listing BSE.NS VIKASLIFE

About VIKAS LIFECARE LIMITED

https://www.vikaslifecarelimited.com

Vikas Lifecare Limited is a diversified enterprise specializing in the manufacturing and trading of polymer and rubber compounds, specialty additives, and chemicals. The company produces high-performance polymer compounds utilized in sectors such as footwear, automotive, and infrastructure. Beyond its core chemical business, it has expanded into the Fast-Moving Consumer Goods (FMCG) and agro-products markets, focusing on the processing and distribution of premium food products. The company also provides infrastructure solutions, specifically in the domain of smart gas metering. A key aspect of its operations is the integration of recycled materials into its production cycles, reflecting a commitment to sustainable manufacturing. Its strategic focus involves vertical integration and portfolio diversification to address evolving industrial and consumer demands.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Listing Compliance Departments of NSE and BSE, dated August 16, 2025, from Vikas Lifecare Limited. It encloses copies of a newspaper advertisement of the company's Un-Audited Financial Results for the quarter ended June 30, 2025. The document references the publication of these results in newspapers and compliance with SEBI regulations. The content is primarily an announcement of the publication of financial results, not the full financial report itself. The document length is 8909 characters, which is relatively short and consistent with an announcement rather than a full interim or quarterly report. There is no detailed financial data or analysis included, only a notification of the results being published in newspapers. Therefore, this document fits best as a Regulatory Filing (RNS) since it is a compliance announcement about the publication of financial results, not the results report itself.
2025-08-16 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Vikas Lifecare Limited dated August 14, 2025, reporting the outcome of a Board Meeting. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2025, along with a Limited Review Report by the auditors. The document also announces a change in an Independent Director and provides related disclosures. The financial results include detailed financial data such as revenue, expenses, profit/loss, and segment reporting. The presence of unaudited quarterly financial results with substantive financial data and an auditor's limited review report indicates this is an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2026
2025-08-14 English
Board Meeting — Financial Results/Other business matters
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about an upcoming Board Meeting scheduled for August 14, 2025. The purpose of the meeting is to consider and approve the un-audited financial results for the quarter ended June 30, 2025. The document references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements but does not contain any actual financial data or results. It is an announcement of a future event (board meeting) rather than a report or detailed financial disclosure. The document length is only 2082 characters, which is quite short and consistent with a regulatory announcement. Therefore, this document fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement and does not qualify as an Interim Report (IR) or Earnings Release (ER).
2025-08-07 English
General Updates
Regulatory Filings Classification · 100% confidence The document is a disclosure made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details an arbitration award related to a consortium acquisition and the financial dispute between Vikas Lifecare Limited and Eraaya Lifespaces Limited. The document includes a letter to the stock exchanges and an annexure providing detailed information about the arbitration matter. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory announcement disclosing a legal/arbitration proceeding outcome to comply with listing regulations. It is not a full audit report, annual report, earnings release, or any other financial report type. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure that does not fit other categories.
2025-07-16 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a letter addressed to the Listing Compliance Department of NSE and BSE, referencing Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It is an annual disclosure confirming that the promoters and persons acting in concert have not made any encumbrance during the financial year ended March 31, 2025. The document is short (1249 characters) and is a regulatory compliance disclosure related to shareholding and encumbrance status, not a financial report or announcement of voting results. This fits the definition of a Major Shareholding Notification (MRQ) as it relates to substantial acquisition and encumbrance disclosures under SEBI regulations.
2025-07-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations. It specifies the period during which insiders are prohibited from trading due to the upcoming announcement of quarterly financial results. The document does not contain any financial data, results, or detailed report but is an announcement related to trading restrictions ahead of financial disclosures. This type of document is a regulatory announcement related to compliance and trading restrictions, not a financial report or earnings release itself. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (1961 characters), and it is clearly an announcement rather than a report or transcript.
2025-06-28 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.